Schroders Capital Global Innovation Trust Steps Up Cash Returns in Managed Wind-Down

Schroder UK Public Private Trust ( (GB:INOV) ) has provided an update.

Schroders Capital Global Innovation Trust plc has shifted fully to an orderly managed wind-down after shareholders backed a discontinuation resolution in early 2025, repositioning the vehicle from growth investing to asset realisation and capital return. The trust has streamlined its board to three directors to contain costs and continues to emphasise direct communication with investors as its portfolio becomes more concentrated and potentially more volatile.

In July 2025, the trust returned £37 million to shareholders via a tender offer funded by the disposal of Araris Biotech, a special dividend from AI Company II and existing cash, and it now intends to return about £18 million more through a further tender offer targeted for June 2026, subject to shareholder approval. Over 2025, net asset value per share rose 11.5% and the share price gained 38.2%, driven largely by gains in the life sciences and growth portfolio, while post year-end the sale of Bluewater Bio via the Salica Environmental Technologies Fund delivered an additional £6.5 million, underpinning further distributions as the wind-down progresses.

More about Schroder UK Public Private Trust

Schroders Capital Global Innovation Trust plc is a listed investment trust focused on innovative, high-growth businesses, with particular exposure to life sciences and technology-driven companies. It is now operating under a managed wind-down strategy, concentrating on realising its private and public portfolio holdings and returning cash to shareholders while maintaining its stock market listing as long as practical.

Average Trading Volume: 735,353

Technical Sentiment Signal: Sell

Find detailed analytics on INOV stock on TipRanks’ Stock Analysis page.